-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vm3JmkACcM6vUi6lIAdIDZj2x3pmLrTXcTtSZGDDahTlsbxAU2aGaqVvY+3cXZJ+ sYjEp1WVJ54J7EkxLdIDAQ== 0001016169-07-000032.txt : 20070514 0001016169-07-000032.hdr.sgml : 20070514 20070514152523 ACCESSION NUMBER: 0001016169-07-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070510 FILED AS OF DATE: 20070514 DATE AS OF CHANGE: 20070514 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA INC CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 250 PHILLIPS BLVD STREET 2: SUITE 290 CITY: EWING STATE: NJ ZIP: 08618 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 250 PHILLIPS BLVD STREET 2: SUITE 290 CITY: EWING STATE: NJ ZIP: 08618 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 FORMER COMPANY: FORMER CONFORMED NAME: MEDI JECT CORP /MN/ DATE OF NAME CHANGE: 19960605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SADOWSKI PETER L CENTRAL INDEX KEY: 0001187592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 07846086 BUSINESS ADDRESS: STREET 1: C/O ANTARES PHARMA INC STREET 2: 707 EAGLEVIEW BLVD SUITE 414 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6104586200 4 1 psadowski051407_ex.xml X0202 4 2007-05-10 0 0001016169 ANTARES PHARMA INC AIS 0001187592 SADOWSKI PETER L C/O ANTARES PHARMA, INC 250 PHILLIPS BLVD, SUITE 290 EWING NJ 08618 0 1 0 0 Vice President Stock Option (right to buy) 1.65 2007-05-10 4 A 0 30000 A 2017-05-09 Common Stock 30000 30000 D The option vests in equal quarterly installments over three years. Not applicable. This represents an interim grant as the Company has changed its policy of issuing annual grants at or near year end to issuing annual grants at the time of the annual meeting of stockholders. Exhibit Index: Exhibit 24, Power of Attorney Robert F. Apple as attorney-in-fact for Peter L. Sadowski 2007-05-14 EX-24 2 ex24.htm

EXHIBIT 24

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that I, Peter L. Sadowski, hereby constitute and appoint Jack E. Stover and Robert F. Apple and each of them, my true and lawful attorneys-in-fact and agents, each acting alone, with full powers of substitution and resubstitution for me and in my name, place and stead, to sign any reports on Form 3 (Initial Statement of Beneficial Ownership), Form 4 (Statement of Changes in Beneficial Ownership of Securities) and Form 5 (Annual Statement of Changes in Beneficial Ownership) relating to transactions by me in Common Stock or other securities of Antares Pharma, Inc., and all amendments thereto, and to file the same with the Securities and Exchange Commission and appropriate securities listing agency, if required, granting unto said attorneys-in-fact and agents, and each of them, or their substitutes, full power and authority to do and perform each and every act and thing requisite or necessary to be done, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and each of them, or their substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney shall be effective until such time as I deliver a written revocation thereof to my above-named attorneys-in-fact and agents.

 

/s/ Peter L. Sadowski  

Peter L. Sadowski

Dated: 5/14/07  

 

 

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----